HEMO
HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Stock London Stock Exchange – Stock Market Prices, News & Analysis
Hemogenyx Pharmaceuticals PLC est une société biopharmaceutique innovante spécialisée dans le développement de thérapies pour le traitement des maladies sévères du sang et le cancer.
HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
HEMO
Hemogenyx Pharmaceuticals PLC est une société biopharmaceutique innovante spécialisée dans le développement de thérapies pour le traitement des maladies sévères du sang et le cancer.
Price history of HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Price history of HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Performance & Momentum
Strategic Analysis
HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 • 2026
Hemogenyx Pharmaceuticals is a UK biopharmaceutical company developing innovative therapies targeting serious blood diseases and cancer, with a differentiated position in cell therapies. Its business model is based on advanced medical research in a niche segment with strong therapeutic and commercial potential.
- Specialization in serious conditions that are often under-treated, creating significant unmet medical need
- Recognized expertise in cell therapies and innovative blood treatments
- High valuation potential linked to promising advances in oncology biotechnology
- A history of significant long-term volatility, which has weighed on investor confidence
- No major recent news, which could limit momentum in the short term
Current momentum is solid, driven by strong medium-term gains that reflect renewed investor interest. This trend supports the valuation and calls for closer attention to the next clinical development milestones or strategic partnerships.
Similar stocks to HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
